<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37103631</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7209</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Angiogenesis</Title><ISOAbbreviation>Angiogenesis</ISOAbbreviation></Journal><ArticleTitle>Damage to endothelial barriers and its contribution to long COVID.</ArticleTitle><Pagination><StartPage>5</StartPage><EndPage>22</EndPage><MedlinePgn>5-22</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10456-023-09878-5</ELocationID><Abstract><AbstractText>The world continues to contend with COVID-19, fueled by the emergence of viral variants. At the same time, a subset of convalescent individuals continues to experience persistent and prolonged sequelae, known as long COVID. Clinical, autopsy, animal and in vitro studies all reveal endothelial injury in acute COVID-19 and convalescent patients. Endothelial dysfunction is now recognized as a central factor in COVID-19 progression and long COVID development. Different organs contain different types of endothelia, each with specific features, forming different endothelial barriers and executing different physiological functions. Endothelial injury results in contraction of cell margins (increased permeability), shedding of glycocalyx, extension of phosphatidylserine-rich filopods, and barrier damage. During acute SARS-CoV-2 infection, damaged endothelial cells promote diffuse microthrombi and destroy the endothelial (including blood-air, blood-brain, glomerular filtration and intestinal-blood) barriers, leading to multiple organ dysfunction. During the convalescence period, a subset of patients is unable to fully recover due to persistent endothelial dysfunction, contributing to long COVID. There is still an important knowledge gap between endothelial barrier damage in different organs and COVID-19 sequelae. In this article, we mainly focus on these endothelial barriers and their contribution to long COVID.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiaoming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Hematology, The First Hospital, Harbin Medical University, 150001, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Mengqi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hematology, The First Hospital, Harbin Medical University, 150001, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Haijiao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Hematology, The First Hospital, Harbin Medical University, 150001, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chengyue</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Hematology, The First Hospital, Harbin Medical University, 150001, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novakovic</LastName><ForeName>Valerie A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Department of Research, VA Boston Healthcare System, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jialan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5642-5436</Identifier><AffiliationInfo><Affiliation>Department of Hematology, The First Hospital, Harbin Medical University, 150001, Harbin, China. jialan_shi@dfci.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Research, VA Boston Healthcare System, Harvard Medical School, Boston, MA, USA. jialan_shi@dfci.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, MA, Boston, USA. jialan_shi@dfci.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Angiogenesis</MedlineTA><NlmUniqueID>9814575</NlmUniqueID><ISSNLinking>0969-6970</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Angiogenesis. 2023 Nov;26(4):481-483. doi: 10.1007/s10456-023-09889-2</RefSource><PMID Version="1">37530975</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Angiogenesis. 2023 Nov;26(4):485-486. doi: 10.1007/s10456-023-09894-5</RefSource><PMID Version="1">37659007</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014652" MajorTopicYN="Y">Vascular Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antithrombotic therapy</Keyword><Keyword MajorTopicYN="N">Endothelial barrier</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>11</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37103631</ArticleId><ArticleId IdType="pmc">PMC10134732</ArticleId><ArticleId IdType="doi">10.1007/s10456-023-09878-5</ArticleId><ArticleId IdType="pii">10.1007/s10456-023-09878-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization (2023)&#xa0;https://covid19.who.int/&#xa0;</Citation></Reference><Reference><Citation>World Health Organization (2021) A clinical case definition of post COVID-19 condition by a Delphi consensus.&#xa0;https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, Lartey S, Onyango TB, Kuwelker K, S&#xe6;vik M, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. 2022;13:1812. doi: 10.1038/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2022;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wettschureck N, Strilic B, Offermanns S. Passing the vascular barrier: endothelial signaling processes controlling extravasation. Physiol Rev. 2019;99(3):1467&#x2013;1525. doi: 10.1152/physrev.00037.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00037.2018</ArticleId><ArticleId IdType="pubmed">31140373</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A, Vecchi&#xe9; A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, Dentali F, Montecucco F, Massberg S, Levi M, Abbate A. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21(5):319&#x2013;329. doi: 10.1038/s41577-021-00536-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00536-9</ArticleId><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, Englert H, Byrne M, Bergin C, O&#x2019;Sullivan JM, et al. Persistent endotheliopathy in the pathogenesis of Long COVID syndrome. J Thromb Haemost. 2021;19:2546&#x2013;2553. doi: 10.1111/jth.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan BE, Wong SW, Sum CLL, Lim GH, Leung BP, Tan CW, Ramanathan K, Dalan R, Cheung C, Lim XR, et al. Hypercoagulability, endotheliopathy, and inflammation approximating 1 year after recovery: assessing the long-term outcomes in COVID-19 patients. Am J Hematol. 2022;97(7):915&#x2013;923. doi: 10.1002/ajh.26575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26575</ArticleId><ArticleId IdType="pmc">PMC9073976</ArticleId><ArticleId IdType="pubmed">35477923</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Joffre J, Rodriguez L, Matthay ZA, Lloyd E, Fields AT, Bainton RJ, Kurien P, Sil A, Calfee CS, Woodruff PG, et al. COVID-19-associated lung microvascular endotheliopathy: a &#x201c;from the bench&#x201d; perspective. Am J Respir Crit Care Med. 2022;206(8):961&#x2013;972. doi: 10.1164/rccm.202107-1774OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202107-1774OC</ArticleId><ArticleId IdType="pmc">PMC9801996</ArticleId><ArticleId IdType="pubmed">35649173</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Han K, Blair R, Kenst K, Qin Z, Upcin B, W&#xf6;rsd&#xf6;rfer P, Midkiff CC, Mudd J, Belyaeva E, et al. SARS-CoV-2 infects endothelial cells in vivo and in vitro. Front Cell Infect Microbiol. 2021;11:701278. doi: 10.3389/fcimb.2021.701278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.701278</ArticleId><ArticleId IdType="pmc">PMC8292147</ArticleId><ArticleId IdType="pubmed">34307198</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y, Zhang J, Schiavon CR, He M, Chen L, Shen H, Zhang Y, Yin Q, Cho Y, Andrade L, et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE2. Circ Res. 2021;128:1323&#x2013;1326. doi: 10.1161/CIRCRESAHA.121.318902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318902</ArticleId><ArticleId IdType="pmc">PMC8091897</ArticleId><ArticleId IdType="pubmed">33784827</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalick L, Weidenfeld S, Grimmer B, Fatykhova D, Solymosi PD, Behrens F, Dohmen M, Brack MC, Schulz S, Thomasch E, et al. Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure. Eur Respir J. 2021;57:2002384. doi: 10.1183/13993003.02384-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02384-2020</ArticleId><ArticleId IdType="pmc">PMC7651836</ArticleId><ArticleId IdType="pubmed">33154030</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett TJ, Cornwell M, Myndzar K, Rolling CC, Xia Y, Drenkova K, Biebuyck A, Fields AT, Tawil M, Luttrell-Williams E, et al. Platelets amplify endotheliopathy in COVID-19. Sci Adv. 2021;7:eabh2434. doi: 10.1126/sciadv.abh2434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abh2434</ArticleId><ArticleId IdType="pmc">PMC8442885</ArticleId><ArticleId IdType="pubmed">34516880</ArticleId></ArticleIdList></Reference><Reference><Citation>Noris M, Benigni A, Remuzzi G. The case of complement activation in COVID-19 multiorgan impact. Kidney Int. 2020;98(2):314&#x2013;322. doi: 10.1016/j.kint.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7246017</ArticleId><ArticleId IdType="pubmed">32461141</ArticleId></ArticleIdList></Reference><Reference><Citation>Halawa S, Pullamsetti SS, Bangham CRM, Stenmark KR, Dorfm&#xfc;ller P, Frid MG, Butrous G, Morrell NW, de Jesus Perez VA, Stuart DI, et al. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective. Nat Rev Cardiol. 2022;19:314&#x2013;331. doi: 10.1038/s41569-021-00640-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00640-2</ArticleId><ArticleId IdType="pmc">PMC8647069</ArticleId><ArticleId IdType="pubmed">34873286</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzali B, Noris M, Lambrecht BN, Kemper C. The state of complement in COVID-19. Nat Rev Immunol. 2022;22(2):77&#x2013;84. doi: 10.1038/s41577-021-00665-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00665-1</ArticleId><ArticleId IdType="pmc">PMC8672651</ArticleId><ArticleId IdType="pubmed">34912108</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupont A, Rauch A, Staessens S, Moussa M, Rosa M, Corseaux D, Jeanpierre E, Goutay J, Caplan M, Varlet P, et al. Vascular endothelial damage in the pathogenesis of organ injury in severe COVID-19. Arterioscler Thromb Vasc Biol. 2021;41:1760&#x2013;1773. doi: 10.1161/ATVBAHA.120.315595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315595</ArticleId><ArticleId IdType="pubmed">33626910</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, Baluha A, Bar N, Bona RD, Burns AJ, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575&#x2013;e582. doi: 10.1016/S2352-3026(20)30216-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30216-7</ArticleId><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, Si Y, Jiang T, Ma R, Zhang Y, Cao M, Li T, Yao Z, Zhao L, Fang S, et al. Phosphotidylserine exposure and neutrophil extracellular traps enhance procoagulant activity in patients with inflammatory bowel disease. Thromb Haemost. 2016;115:738&#x2013;751. doi: 10.1160/TH15-09-0710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH15-09-0710</ArticleId><ArticleId IdType="pubmed">26660948</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaumenhaft R, Enjyoji K, Schmaier AA. Vasculopathy in COVID-19. Blood. 2022;140(3):222&#x2013;235. doi: 10.1182/blood.2021012250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021012250</ArticleId><ArticleId IdType="pmc">PMC8736280</ArticleId><ArticleId IdType="pubmed">34986238</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh FW, Fong SW, Young BE, Wu KX, Siau A, Krishnan S, Chan YH, Carissimo G, Teo LL, Gao F, et al. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife. 2021;10:e64909. doi: 10.7554/eLife.64909.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64909</ArticleId><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanoli L, Gaudio A, Mikhailidis DP, Katsiki N, Castellino N, Lo Cicero L, Geraci G, Sessa C, Fiorito L, Marino F, et al. Vascular dysfunction of COVID-19 is partially reverted in the long-term. Circ Res. 2022;130(9):1276&#x2013;1285. doi: 10.1161/CIRCRESAHA.121.320460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.320460</ArticleId><ArticleId IdType="pubmed">35345906</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambadiari V, Mitrakou A, Kountouri A, Thymis J, Katogiannis K, Korakas E, Varlamos C, Andreadou I, Tsoumani M, Triantafyllidi H, et al. Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection. Eur J Heart Fail. 2021;23(11):1916&#x2013;1926. doi: 10.1002/ejhf.2326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2326</ArticleId><ArticleId IdType="pmc">PMC8426810</ArticleId><ArticleId IdType="pubmed">34415085</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, Pfister A, Meyer M, R&#xf6;ssler A, Kimpel J, Adolph TE, Tilg H, et al. Post-acute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163(2):495&#x2013;506. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung CCL, Goh D, Lim X, Tien TZ, Lim JCT, Lee JN, Tan B, Tay ZEA, Wan WY, Chen EX, et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. 2022;71(1):226&#x2013;229. doi: 10.1136/gutjnl-2021-324280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F, Chen F, Ou Z, Fan Q, Tan X, Wang Y, Pan Y, Ke B, Li L, Guan Y, et al. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell Mol immunol. 2020;17(11):1119&#x2013;1125. doi: 10.1038/s41423-020-00550-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00550-2</ArticleId><ArticleId IdType="pmc">PMC7546387</ArticleId><ArticleId IdType="pubmed">33037400</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurath MF, &#xdc;berla K, Ng SC. Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19. Gut. 2021;70(9):1605&#x2013;1608. doi: 10.1136/gutjnl-2021-324622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324622</ArticleId><ArticleId IdType="pubmed">33903146</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, Khunti K, Alwan NA, Walker AS. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Arkin LM, Moon JJ, Tran JM, Asgari S, O&#x2019;Farrelly C, Casanova JL, Cowen EW, Mays JW, Singh AM, Drolet BA, COVID Human Genetic Effort From your nose to your toes: a review of severe acute respiratory syndrome coronavirus 2 pandemic-associated pernio. J Invest Dermatol. 2021;141(12):2791&#x2013;2796. doi: 10.1016/j.jid.2021.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jid.2021.05.024</ArticleId><ArticleId IdType="pmc">PMC8279931</ArticleId><ArticleId IdType="pubmed">34561087</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, De Martino M, Palese A, Gerussi V, Bontempo G, Graziano E, Visintini E, D&#x2019;Elia D, Dellai F, Marrella F, et al. Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients. Clin Microbiol Infect. 2022;28(8):1140&#x2013;1148. doi: 10.1016/j.cmi.2022.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.03.016</ArticleId><ArticleId IdType="pmc">PMC8940723</ArticleId><ArticleId IdType="pubmed">35339673</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022;10(8):761&#x2013;775. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, Juno JA, Burrell LM, Kent SJ, Dore GJ, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, Boustani K, Ogger PP, Papadaki A, Tonkin J, Orton CM, Ghai P, Suveizdyte K, Hewitt RJ, Desai SR, et al. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity. 2022;55(3):542&#x2013;556e5. doi: 10.1016/j.immuni.2022.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.017</ArticleId><ArticleId IdType="pmc">PMC8789571</ArticleId><ArticleId IdType="pubmed">35151371</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M, Sali&#xe9; H, Tanevski J, Killmer S, Lago MS, Schlaak AE, Mayer L, Matschke J, P&#xfc;schel K, Fitzek A, et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021;54(7):1594&#x2013;1610e11. doi: 10.1016/j.immuni.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiaevi I, Schulze A, Evers G, Harmening K, Vink H, K&#xfc;mpers P, Mohr M, Rovas A. Persistent capillary rarefication in long COVID syndrome. Angiogenesis. 2023;26(1):53&#x2013;61. doi: 10.1007/s10456-022-09850-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-022-09850-9</ArticleId><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczykowski C, Mardin C, Lucio M, Wallukat G, Hoffmanns J, Schr&#xf6;der T, Raith F, Rogge L, Heltmann F, Moritz M, et al. Long COVID: association of functional autoantibodies against G-protein-coupled receptors with an impaired retinal microcirculation. Int J Mol Sci. 2022;23(13):7209. doi: 10.3390/ijms23137209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137209</ArticleId><ArticleId IdType="pmc">PMC9266742</ArticleId><ArticleId IdType="pubmed">35806214</ArticleId></ArticleIdList></Reference><Reference><Citation>Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev. 2013;93:327&#x2013;358. doi: 10.1152/physrev.00016.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00016.2011</ArticleId><ArticleId IdType="pubmed">23303912</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao M, Li T, He Z, Wang L, Yang X, Kou Y, Zou L, Dong X, Novakovic VA, Bi Y, Kou J, et al. Promyelocytic extracellular chromatin exacerbates coagulation and fibrinolysis in acute promyelocytic leukemia. Blood. 2017;129(13):1855&#x2013;1864. doi: 10.1182/blood-2016-09-739334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-09-739334</ArticleId><ArticleId IdType="pmc">PMC5374289</ArticleId><ArticleId IdType="pubmed">28053193</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Gilbert GE. Lactadherin inhibits enzyme complexes of blood coagulation by completing for phospholipid binding sites. Blood. 2003;101:2628&#x2013;2636. doi: 10.1182/blood-2002-07-1951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2002-07-1951</ArticleId><ArticleId IdType="pubmed">12517809</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas M, Scully M. Clinical features of thrombosis and bleeding in COVID-19. Blood. 2022;385:1680&#x2013;1689. doi: 10.1182/blood.2021012247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021012247</ArticleId><ArticleId IdType="pmc">PMC9040438</ArticleId><ArticleId IdType="pubmed">35452509</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, Fonseca-Rodr&#xed;guez O, Farrington P, Jerndal H, Lundevaller EH, Sund M, Lindmark K, Fors Connolly AM. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ. 2022;377:e069590. doi: 10.1056/NEJMoa2109908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2109908</ArticleId><ArticleId IdType="pmc">PMC8984137</ArticleId><ArticleId IdType="pubmed">35387772</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T, Levy JH. Derangement of the endothelial glycocalyx in sepsis. J Thromb Haemost. 2019;17(2):283&#x2013;294. doi: 10.1111/jth.14371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14371</ArticleId><ArticleId IdType="pubmed">30582882</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadja DM, Mentzer SJ, Fontenay M, Laffan MA, Ackermann M, Helms J, Jonigk D, Chocron R, Pier GB, Gendron N, et al. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis. 2021;24:755&#x2013;788. doi: 10.1007/s10456-021-09805-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-021-09805-6</ArticleId><ArticleId IdType="pmc">PMC8238037</ArticleId><ArticleId IdType="pubmed">34184164</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollenberg R, Tepasse PR, Ochs K, Floer M, Strauss M, Rennebaum F, Kabar I, Rovas A, Nowacki T. Indications of persistent glycocalyx damage in convalescent COVID-19 patients: a prospective multicenter study and hypothesis. Virus. 2021;13(11):2324. doi: 10.3390/v13112324.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112324</ArticleId><ArticleId IdType="pmc">PMC8619155</ArticleId><ArticleId IdType="pubmed">34835130</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovas A, Osiaevi I, Buscher K, Sackarnd J, Tepasse PR, Fobker M, K&#xfc;hn J, Braune S, G&#xf6;bel U, Th&#xf6;lking G, et al. Microvascular dysfunction in COVID-19: the MYSTIC study. Angiogenesis. 2021;24(1):145&#x2013;157. doi: 10.1007/s10456-020-09753-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-020-09753-7</ArticleId><ArticleId IdType="pmc">PMC7556767</ArticleId><ArticleId IdType="pubmed">33058027</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonomidis I, Lambadiari V, Mitrakou A, Kountouri A, Katogiannis K, Thymis J, Korakas E, Pavlidis G, Kazakou P, Panagopoulos G, et al. Myocardial work and vascular dysfunction are partially improved at 12 months after COVID-19 infection. Eur J Heart Fail. 2022;24(4):727&#x2013;729. doi: 10.1002/ejhf.2451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2451</ArticleId><ArticleId IdType="pmc">PMC9087421</ArticleId><ArticleId IdType="pubmed">35138689</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agnillo F, Walters KA, Xiao Y, Sheng ZM, Scherler K, Park J, Gygli S, Rosas LA, Sadtler K, Kalish H, et al. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci Transl Med. 2021;13(620):eabj7790. doi: 10.1126/scitranslmed.abj7790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abj7790</ArticleId><ArticleId IdType="pmc">PMC11000440</ArticleId><ArticleId IdType="pubmed">34648357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Perl DP, Nair G, Li W, Maric D, Murray H, Dodd SJ, Koretsky AP, Watts JA, Cheung V, et al. Microvascular injury in the brains of patients with Covid-19. N Engl J Med. 2021;384:481&#x2013;483. doi: 10.1056/NEJMc2033369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Daehn IS, Duffield JS. The glomerular filtration barrier: a structural target for novel kidney therapies. Nat Rev Drug Discov. 2021;20:770&#x2013;788. doi: 10.1038/s41573-021-00242-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-021-00242-0</ArticleId><ArticleId IdType="pmc">PMC8278373</ArticleId><ArticleId IdType="pubmed">34262140</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Jing H, Wang C, Wang Y, Zuo N, Jiang T, Novakovic VA, Shi J. Intestinal damage in COVID-19: SARS-CoV-2 infection and intestinal thrombosis. Front Microbiol. 2022;13:860931. doi: 10.3389/fmicb.2022.860931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.860931</ArticleId><ArticleId IdType="pmc">PMC8981312</ArticleId><ArticleId IdType="pubmed">35391725</ArticleId></ArticleIdList></Reference><Reference><Citation>Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Cir Res. 2007;100(2):174&#x2013;190. doi: 10.1161/01.RES.0000255690.03436.ae.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000255690.03436.ae</ArticleId><ArticleId IdType="pubmed">17272819</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rew Microbiol. 2022;20(5):270&#x2013;284. doi: 10.1038/s41579-022-00713-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00713-0</ArticleId><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA, da Silva LFF, de Oliveira EP, Saldiva PHN, Mauad T, Negri EM. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost. 2020;18:1517&#x2013;1519. doi: 10.1111/jth.14844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14844</ArticleId><ArticleId IdType="pmc">PMC7262093</ArticleId><ArticleId IdType="pubmed">32294295</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris MF, Pershad Y, Kang P, Ridenour L, Lavon B, Lanclus M, Godon R, De Backer J, Glassberg MK. Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease. Eur Respir J. 2021;58:2004133. doi: 10.1183/13993003.04133-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.04133-2020</ArticleId><ArticleId IdType="pmc">PMC7908189</ArticleId><ArticleId IdType="pubmed">33632795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Tafforeau P, Wagner WL, Walsh CL, Werlein C, K&#xfc;hnel MP, L&#xe4;nger FP, Disney C, Bodey AJ, Bellier A, et al. The bronchial circulation in COVID-19 pneumonia. Am J Respir Crit Care Med. 2022;205(1):121&#x2013;125. doi: 10.1164/rccm.202103-0594IM.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202103-0594IM</ArticleId><ArticleId IdType="pmc">PMC8865596</ArticleId><ArticleId IdType="pubmed">34734553</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, Kurz K, Koppelst&#xe4;tter S, Haschka D, Petzer V, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57(4):2003481. doi: 10.1183/13993003.03481-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03481-2020</ArticleId><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravaglia C, Doglioni C, Chilosi M, Piciucchi S, Dubini A, Rossi G, Pedica F, Puglisi S, Donati L, Tomassetti S, Poletti V. Clinical, radiological, and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection. Eur Respir J. 2022;60(4):2102411. doi: 10.1183/13993003.02411-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02411-2021</ArticleId><ArticleId IdType="pmc">PMC8932282</ArticleId><ArticleId IdType="pubmed">35301248</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon IS, Li C, Son YM, Goplen NP, Wu Y, Cassmann T, Wang Z, Wei X, Tang J, Li Y, et al. Immune signatures underlying post-acute COVID-19 lung sequelae. Sci Immunol. 2021;6(65):eabk1741. doi: 10.1126/sciimmunol.abk1741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abk1741</ArticleId><ArticleId IdType="pmc">PMC8763087</ArticleId><ArticleId IdType="pubmed">34591653</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri L, Moss S, Khan FA, Chi W, Xia J, Robinson K, Smyth AR, Jenkins G, Stewart I. Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis. Thorax. 2022;78(2):191&#x2013;201. doi: 10.1136/thoraxjnl-2021-218275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-218275</ArticleId><ArticleId IdType="pubmed">35338102</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendisch D, Dietrich O, Mari T, von Stillfried S, Ibarra IL, Mittermaier M, Mache C, Chua RL, Knoll R, Timm S, et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021;184(26):6243&#x2013;6261e27. doi: 10.1016/j.cell.2021.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.11.033</ArticleId><ArticleId IdType="pmc">PMC8626230</ArticleId><ArticleId IdType="pubmed">34914922</ArticleId></ArticleIdList></Reference><Reference><Citation>Roach A, Chikwe J, Catarino P, Rampolla R, Noble PW, Megna D, Chen Q, Emerson D, Egorova N, Keshavjee S, Kirklin JK. Lung transplantation for Covid-19-related respiratory failure in the United States. N Engl J Med. 2022;386(12):1187&#x2013;1188. doi: 10.1056/NEJMc2117024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2117024</ArticleId><ArticleId IdType="pmc">PMC8809503</ArticleId><ArticleId IdType="pubmed">35081299</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, Rajaratnam K, Watson BW, Kell DB. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID/Post-Acute sequelae of COVID-19 (PASC) Cardiovasc Diabetol. 2022;21(1):148. doi: 10.1186/s12933-022-01579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins-Gon&#xe7;alves R, Campos MM, Palhinha L, Azevedo-Quintanilha IG, Abud Mendes M, Ramos Temerozo J, Toledo-Mendes J, Rosado-de-Castro PH, Bozza FA, Souza Rodrigues R, et al. Persisting platelet activation and hyperactivity in COVID-19 survivors. Circ Res. 2022;131(11):944&#x2013;947. doi: 10.1161/CIRCRESAHA.122.321659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.321659</ArticleId><ArticleId IdType="pmc">PMC9645447</ArticleId><ArticleId IdType="pubmed">36268747</ArticleId></ArticleIdList></Reference><Reference><Citation>Werlein C, Ackermann M, Stark H, Shah HR, Tzankov A, Haslbauer JD, von Stillfried S, B&#xfc;low RD, El-Armouche A, Kuenzel S, et al. Inflammation and vascular remodeling in COVID-19 hearts. Angiogenesis. 2022 doi: 10.1007/s10456-022-09860-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-022-09860-7</ArticleId><ArticleId IdType="pmc">PMC9660162</ArticleId><ArticleId IdType="pubmed">36371548</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan RT, Gopalan D, Howard L, Vicente A, Park M, Manalan K, Wallner I, Marsden P, Dave S, Branley H, Russell G, Dharmarajah N, Kon OM. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med. 2021;9(1):107&#x2013;116. doi: 10.1016/S2213-2600(20)30407-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30407-0</ArticleId><ArticleId IdType="pmc">PMC7833494</ArticleId><ArticleId IdType="pubmed">33217366</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood&#x2013;brain barrier: from physiology to disease and back. Physiol Rev. 2019;99(1):21&#x2013;78. doi: 10.1152/physrev.00050.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00050.2017</ArticleId><ArticleId IdType="pmc">PMC6335099</ArticleId><ArticleId IdType="pubmed">30280653</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt B, Vajkoczy P, Weller RO. The movers and shapers in immune privilege of the CNS. Nat Immunol. 2017;18(2):123&#x2013;131. doi: 10.1038/ni.3666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3666</ArticleId><ArticleId IdType="pubmed">28092374</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28(11):2406&#x2013;2415. doi: 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375(6578):267&#x2013;269. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake TM, Riad AM, Fairfield CJ, Egan C, Knight SR, Pius R, Hardwick HE, Norman L, Shaw CA, McLean KA, et al. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet. 2021;398(10296):223&#x2013;237. doi: 10.1016/S0140-6736(21)00799-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00799-6</ArticleId><ArticleId IdType="pmc">PMC8285118</ArticleId><ArticleId IdType="pubmed">34274064</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur KT, Miller EH, Glendinning MD, Al-Dalahmah O, Banu MA, Boehme AK, Boubour AL, Bruce SS, Chong AM, Claassen J, et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain. 2021;144(9):2696&#x2013;2708. doi: 10.1093/brain/awab148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab148</ArticleId><ArticleId IdType="pmc">PMC8083258</ArticleId><ArticleId IdType="pubmed">33856027</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Perl DP, Steiner J, Pasternack N, Li W, Maric D, Safavi F, Horkayne-Szakaly I, Jones R, Stram MN, et al. Neurovascular injury with complement activation and inflammation in COVID-19. Brain. 2022;145(7):2555&#x2013;2568. doi: 10.1093/brain/awac151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac151</ArticleId><ArticleId IdType="pmc">PMC9278212</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>De Michele M, Kahan J, Berto I, Schiavo OG, Iacobucci M, Toni D, Merkler AE. Cerebrovascular complications of COVID-19 and COVID-19 vaccination. Cir Res. 2022;130(8):1187&#x2013;1203. doi: 10.1161/CIRCRESAHA.122.319954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.319954</ArticleId><ArticleId IdType="pmc">PMC9005103</ArticleId><ArticleId IdType="pubmed">35420916</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsanos AH, Palaiodimou L, Zand R, Yaghi S, Kamel H, Navi BB, Turc G, Romoli M, Sharma VK, Mavridis D, et al. The impact of SARS-CoV-2 on stroke epidemiology and care: a meta-analysis. Ann Neurol. 2021;89(3):380&#x2013;388. doi: 10.1002/ana.25967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25967</ArticleId><ArticleId IdType="pmc">PMC7753413</ArticleId><ArticleId IdType="pubmed">33219563</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldrop G, Safavynia SA, Barra ME, Agarwal S, Berlin DA, Boehme AK, Brodie D, Choi JM, Doyle K, Fins JJ, et al. Prolonged unconsciousness is common in COVID-19 and associated with hypoxemia. Ann Neurol. 2022;91(6):740&#x2013;755. doi: 10.1002/ana.26342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26342</ArticleId><ArticleId IdType="pmc">PMC9082460</ArticleId><ArticleId IdType="pubmed">35254675</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I, Mayer MG, Hellmers LM, Ning B, Huang Z, Monjure CJ, Coyne C, Silvestri R, Golden N, Hensley K, et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat Commun. 2022;13(1):1745. doi: 10.1038/s41467-022-29440-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, Bullock TA, McGary HM, Khan JA, Razmpour R, Hale JF, Galie PA, Potula R, et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood&#x2013;brain barrier. Neurobiol Dis. 2020;146:105131. doi: 10.1016/j.nbd.2020.105131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105131</ArticleId><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson MA, Banks WA. Neuroimmune axes of the blood&#x2013;brain barriers and blood&#x2013;brain interfaces: bases for physiological regulation, disease states, and pharmacological interventions. Pharmacol Rev. 2018;70(2):278&#x2013;314. doi: 10.1124/pr.117.014647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.117.014647</ArticleId><ArticleId IdType="pmc">PMC5833009</ArticleId><ArticleId IdType="pubmed">29496890</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks WA, Farr SA, La Scola ME, Morley JE. Intravenous human interleukin-1alpha impairs memory processing in mice: dependence on blood&#x2013;brain barrier transport into posterior division of the septum. J Pharmacol Exp Ther. 2001;299(2):536&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pubmed">11602664</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi G, Aluise CD, Cole MP, Sultana R, Pierce WM, Vore M, St Clair DK, Butterfield DA. Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain. Neuroscience. 2010;166(3):796&#x2013;807. doi: 10.1016/j.neuroscience.2010.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.01.021</ArticleId><ArticleId IdType="pmc">PMC2852883</ArticleId><ArticleId IdType="pubmed">20096337</ArticleId></ArticleIdList></Reference><Reference><Citation>Busatto GF, de Araujo AL, Castaldelli-Maia JM, Damiano RF, Imamura M, Guedes BF, Pinna FR, Sawamura MVY, Mancini MC, da Silva KR, et al. Post-acute sequelae of SARS-CoV-2 infection: relationship of central nervous system manifestations with physical disability and systemic inflammation. Psychol Med. 2022;52(12):2387&#x2013;2398. doi: 10.1017/S0033291722001374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291722001374</ArticleId><ArticleId IdType="pmc">PMC9151630</ArticleId><ArticleId IdType="pubmed">35521752</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari C, Sorbi S. The complexity of Alzheimer&#x2019;s disease: an evolving puzzle. Physiol Rev. 2021;101(3):1047&#x2013;1081. doi: 10.1152/physrev.00015.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00015.2020</ArticleId><ArticleId IdType="pubmed">33475022</ArticleId></ArticleIdList></Reference><Reference><Citation>Jourde-Chiche N, Fakhouri F, Dou L, Bellien J, Burtey S, Frimat M, Jarrot PA, Kaplanski G, Le Quintrec M, Pernin V, et al. Endothelium structure and function in kidney health and disease. Nat Rev Nephrol. 2019;15(2):87&#x2013;108. doi: 10.1038/s41581-018-0098-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-018-0098-z</ArticleId><ArticleId IdType="pubmed">30607032</ArticleId></ArticleIdList></Reference><Reference><Citation>Yende S, Parikh CR. Long COVID and kidney disease. Nat Rev Nephrol. 2021;17(12):792&#x2013;793. doi: 10.1038/s41581-021-00487-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00487-3</ArticleId><ArticleId IdType="pmc">PMC8427150</ArticleId><ArticleId IdType="pubmed">34504319</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K, Cantaluppi V. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol. 2021;17(11):751&#x2013;764. doi: 10.1038/s41581-021-00452-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00452-0</ArticleId><ArticleId IdType="pmc">PMC8256398</ArticleId><ArticleId IdType="pubmed">34226718</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P, Uppal NN, Wanchoo R, Shah HH, Yang Y, Parikh R, Khanin Y, Madireddy V, Larsen CP, Jhaveri KD, et al. COVID-19-associated kidney injury: a case series of kidney biopsy findings. J Am Soc Nephrol. 2020;31(9):1948&#x2013;1958. doi: 10.1681/ASN.2020050699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020050699</ArticleId><ArticleId IdType="pmc">PMC7461689</ArticleId><ArticleId IdType="pubmed">32660970</ArticleId></ArticleIdList></Reference><Reference><Citation>Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, Yi F, Yang HC, Fogo AB, Nie X, Zhang C. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219&#x2013;227. doi: 10.1016/j.kint.2020.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.04.003</ArticleId><ArticleId IdType="pmc">PMC7194105</ArticleId><ArticleId IdType="pubmed">32327202</ArticleId></ArticleIdList></Reference><Reference><Citation>Volbeda M, Jou-Valencia D, van den Heuvel MC, Knoester M, Zwiers PJ, Pillay J, Berger SP, van der Voort PHJ, Zijlstra JG, van Meurs M, Moser J. Comparison of renal histopathology and gene expression profiles between severe COVID-19 and bacterial sepsis in critically ill patients. Crit Care. 2021;25(1):202. doi: 10.1186/s13054-021-03631-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03631-4</ArticleId><ArticleId IdType="pmc">PMC8190989</ArticleId><ArticleId IdType="pubmed">34112226</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Xu E, Al-Aly Z. Kidney outcomes in long COVID. J Am Soc Nephrol. 2021;32(11):2851&#x2013;2862. doi: 10.1681/ASN.2021060734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021060734</ArticleId><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>Idilman IS, Telli Dizman G, Ardali Duzgun S, Irmak I, Karcaaltincaba M, Inkaya AC, Demirkazik F, Durhan G, Gulsun Akpinar M, Ariyurek OM, et al. Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy. Eur Radiol. 2021;31(2):1090&#x2013;1099. doi: 10.1007/s00330-020-07155-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-020-07155-3</ArticleId><ArticleId IdType="pmc">PMC7455509</ArticleId><ArticleId IdType="pubmed">32860146</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, L&#xfc;tgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, Chilla S, Heinemann A, Wanner N, Liu S, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383(6):590&#x2013;592. doi: 10.1056/NEJMc2011400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadoni I, Fornasa G, Rescigno M. Organ-specific protection mediated by cooperation between vascular and epithelial barriers. Nat Rev Immunol. 2017;17(12):761&#x2013;773. doi: 10.1038/nri.2017.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.100</ArticleId><ArticleId IdType="pubmed">28869253</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaiss CA, Zmora N, Levy M, Elinav E. The microbiome and innate immunity. Nature. 2016;535(7610):65&#x2013;74. doi: 10.1038/nature18847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18847</ArticleId><ArticleId IdType="pubmed">27383981</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, Ng YY, Chu MY, Chung TWH, Tam AR, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in faecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020;159:81&#x2013;95. doi: 10.1053/j.gastro.2020.03.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.03.065</ArticleId><ArticleId IdType="pmc">PMC7194936</ArticleId><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, Wan Y, Chung ACK, Cheung CP, Chen N, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3):944&#x2013;955. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK, et al. AGA institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology. 2020;159(1):320&#x2013;334e27. doi: 10.1053/j.gastro.2020.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7212965</ArticleId><ArticleId IdType="pubmed">32407808</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H, Chen Y, Li J, Li H, Zhao X, Li J, Yang F, Li Y, Liu C, Qin L, et al. Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques. Cell Rep. 2022;39(8):110864. doi: 10.1016/j.celrep.2022.111014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111014</ArticleId><ArticleId IdType="pmc">PMC9080054</ArticleId><ArticleId IdType="pubmed">35594870</ArticleId></ArticleIdList></Reference><Reference><Citation>Norsa L, Bonaffini PA, Indriolo A, Valle C, Sonzogni A, Sironi S. Poor outcome of intestinal ischemic manifestations of COVID-19. Gastroenterology. 2020;159(4):1595&#x2013;1597e1. doi: 10.1053/j.gastro.2020.06.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.06.041</ArticleId><ArticleId IdType="pmc">PMC7305715</ArticleId><ArticleId IdType="pubmed">32569772</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau RI, Zhang F, Liu Q, Su Q, Chan FKL, Ng SC. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications. Nat Rev Gastroenterol Hepatol. 2022 doi: 10.1038/s41575-022-00698-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00698-4</ArticleId><ArticleId IdType="pmc">PMC9589856</ArticleId><ArticleId IdType="pubmed">36271144</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC, Ng SSS, Zhang F, Li AYL, Lu W, Hui DS, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71(3):544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestad B, Ueland T, Lerum TV, Dahl TB, Holm K, Barratt-Due A, K&#xe5;sine T, Dyrhol-Riise AM, Stiksrud B, Tonby K, et al. Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations. J Intern Med. 2022;291(6):801&#x2013;812. doi: 10.1111/joim.13458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13458</ArticleId><ArticleId IdType="pmc">PMC9115297</ArticleId><ArticleId IdType="pubmed">35212063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wu G, Zhao L, Wang W. Nutritional modulation of gut microbiota alleviates severe gastrointestinal symptoms in a patient with post-acute COVID-19 syndrome. mBio. 2022;13(2):e0380121. doi: 10.1128/mbio.03801-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.03801-21</ArticleId><ArticleId IdType="pmc">PMC9040862</ArticleId><ArticleId IdType="pubmed">35254129</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, Canas LS, Graham MS, Klaser K, Modat M, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, Levi R, Sarti R, Pozzi C, Mollura M, Mantovani A, Rescigno M. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. 2022;328(7):676&#x2013;678. doi: 10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou E, Souvaliotis N, Lampsas S, Siasos G, Poulakou G, Theofilis P, Papaioannou TG, Haidich AB, Tsaousi G, Ntousopoulos V, et al. Endothelial dysfunction in acute and long standing COVID-19: a prospective cohort study. Vascul Pharmacol. 2022;144:106975. doi: 10.1016/j.vph.2022.106975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2022.106975</ArticleId><ArticleId IdType="pmc">PMC8893931</ArticleId><ArticleId IdType="pubmed">35248780</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Bowe B, Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat Commun. 2021;12(1):6571. doi: 10.1038/s41467-021-26513-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26513-3</ArticleId><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee for the REMAP-&#x2009;&#x2009;CAP. Investigators, Higgins AM, Berry LR, Lorenzi E, Murthy S, McQuilten Z, Mouncey PR, Al-Beidh F, Annane D, Arabi YM, et al. Long-term (180-Day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial. JAMA. 2023;329(1):39&#x2013;51. doi: 10.1001/jama.2022.23257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.23257</ArticleId><ArticleId IdType="pmc">PMC9857594</ArticleId><ArticleId IdType="pubmed">36525245</ArticleId></ArticleIdList></Reference><Reference><Citation>Voci D, G&#xf6;tschi A, Held U, Bingisser R, Colucci G, Duerschmied D, Fumagalli RM, Gerber B, Hasse B, Keller D, et al. Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial. Thromb Res. 2023;221:157&#x2013;163. doi: 10.1016/j.thromres.2022.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2022.10.021</ArticleId><ArticleId IdType="pmc">PMC9657896</ArticleId><ArticleId IdType="pubmed">36396519</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannis D, Allen SL, Tsang J, Flint S, Pinhasov T, Williams S, Tan G, Thakur R, Leung C, Snyder M, et al. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood. 2021;137(20):2838&#x2013;2847. doi: 10.1182/blood.2020010529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020010529</ArticleId><ArticleId IdType="pmc">PMC8032474</ArticleId><ArticleId IdType="pubmed">33824972</ArticleId></ArticleIdList></Reference><Reference><Citation>Motloch LJ, Jirak P, Mirna M, Fiedler L, Davtyan PA, Lakman IA, Gareeva DF, Tyurin AV, Gumerov RM, et al. Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors. Front Cardiovasc Med. 2022;9:916156. doi: 10.3389/fcvm.2022.916156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.916156</ArticleId><ArticleId IdType="pmc">PMC9372296</ArticleId><ArticleId IdType="pubmed">35966512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramacciotti E, Barile Agati L, Calderaro D, Aguiar VCR, Spyropoulos AC, de Oliveira CCC, et al. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial. Lancet. 2022;399(10319):50&#x2013;59. doi: 10.1016/S0140-6736(21)02392-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02392-8</ArticleId><ArticleId IdType="pmc">PMC8673881</ArticleId><ArticleId IdType="pubmed">34921756</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibnhadjamor H, Jdidi J, Torjmen S, Kraiem S, Bahloul A, Makni A, Kallel N, Moussa N, Boudaya M, et al. Sulodexide significantly improves endothelial dysfunction and alleviates chest pain and palpitations in patients with long-COVID-19: insights from TUN-EndCOV Study. Front Cardiovasc Med. 2022;9:866113. doi: 10.3389/fcvm.2022.866113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.866113</ArticleId><ArticleId IdType="pmc">PMC9133483</ArticleId><ArticleId IdType="pubmed">35647070</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubsher GJ, Kotze MJ, Moremi K, Oladejo S, et al. Combined triple treatment of fibrin amyloid microclots and platelet pathology in individuals with long COVID/post-acute sequelae of COVID-19 (PASC) can resolve their persistent symptoms. Res Square. 2022;21(1):148. doi: 10.21203/rs.3.rs-1205453/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1205453/v1</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kooistra E, Heesakkers H, Pickkers P, Zegers M, van den Boogaard M. Long-term impairments are most pronounced in critically ill patients with COVID-19 with severe obesity. Am J Respir Crit Care Med. 2022;206(8):1037&#x2013;1039. doi: 10.1164/rccm.202202-0376LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202202-0376LE</ArticleId><ArticleId IdType="pmc">PMC9801993</ArticleId><ArticleId IdType="pubmed">35696647</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;895. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Florencio LL, Fern&#xe1;ndez-de-Las-Pe&#xf1;as C. Long COVID: systemic inflammation and obesity as therapeutic targets. Lancet Respir Med. 2022;10(8):726&#x2013;727. doi: 10.1016/S2213-2600(22)00159-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00159-X</ArticleId><ArticleId IdType="pmc">PMC9034853</ArticleId><ArticleId IdType="pubmed">35472305</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunti K, Davies MJ, Kosiborod MN, Nauck MA. Long COVID-metabolic risk factors and novel therapeutic management. Nat Rev Endocrinol. 2021;17(7):379&#x2013;380. doi: 10.1038/s41574-021-00495-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-021-00495-0</ArticleId><ArticleId IdType="pmc">PMC8054121</ArticleId><ArticleId IdType="pubmed">33875855</ArticleId></ArticleIdList></Reference><Reference><Citation>Armando F, Beythien G, Kaiser FK, Allnoch L, Heydemann L, Rosiak M, Becker S, Gonzalez-Hernandez M, Lamers MM, Haagmans BL, et al. SARS-CoV-2 omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters. Nat Commun. 2022;12(1):3519. doi: 10.1038/s41467-022-31200-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31200-y</ArticleId><ArticleId IdType="pmc">PMC9207884</ArticleId><ArticleId IdType="pubmed">35725735</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Covid-19: hospital admission 50&#x2013;70% less likely with omicron than delta, but transmission a major concern. BMJ. 2021;375:N3151. doi: 10.1136/bmj.n3151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n3151</ArticleId><ArticleId IdType="pubmed">34952835</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K, Kristoffersen DT, Dell&#x2019;Isola A, Kiadaliri A, Turkiewicz A, Runhaar J, Bierma-Zeinstra S, Englund M, Magnus PM, Kinge JM. Post-covid medical complaints following infection with SARS-CoV-2 omicron vs delta variants. Nat Commun. 2022;13(1):7363. doi: 10.1038/s41467-022-35240-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35240-2</ArticleId><ArticleId IdType="pmc">PMC9709355</ArticleId><ArticleId IdType="pubmed">36450749</ArticleId></ArticleIdList></Reference><Reference><Citation>European Congress of Microbiology &amp; Infectious Diseases (2022) Different SARS-CoV-2 variants may give rise to different long COVID symptoms, study suggests. https://www.eurekalert.org/news-releases/947495</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang NNY, So HC, Cowling BJ, Leung GM, Ip DKM. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study. Lancet Infect Dis. 2022 doi: 10.1016/S1473-3099(22)00732-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00732-0</ArticleId><ArticleId IdType="pmc">PMC9744442</ArticleId><ArticleId IdType="pubmed">36521506</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodbridge Y, Amit S, Huppert A, Kopelman NM. Viral load dynamics of SARS-CoV-2 delta and omicron variants following multiple vaccine doses and previous infection. Nat Commun. 2022;13(1):6706. doi: 10.1038/s41467-022-33096-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33096-0</ArticleId><ArticleId IdType="pmc">PMC9640564</ArticleId><ArticleId IdType="pubmed">36344489</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Vetter P, Chappuis F, Kaiser L, Guessous I, CoviCare Study Team Prevalence of post-COV condition 12 weeks after omicron infection compared to negative controls and association with vaccination status. Clin Infect Dis. 2022 doi: 10.1093/cid/ciac947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac947</ArticleId><ArticleId IdType="pubmed">36519381</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar LM, Kruger A, Venter C, Burger EM, Laubscher GJ, Maponga TG, Kotze MJ, Kwaan HC, Miller JB, Fulkerson D, et al. Relative hypercoagulopathy of the SARS-CoV-2 beta and delta variants when compared to the less severe omicron variants is related to TEG parameters, the extent of fibrin amyloid microclots, and the severity of clinical illness. Semin Thromb Hemost. 2022;48(7):858&#x2013;868. doi: 10.1055/s-0042-1756306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1756306</ArticleId><ArticleId IdType="pubmed">36174604</ArticleId></ArticleIdList></Reference><Reference><Citation>Skow RJ, Nandadeva D, Grotle AK, Stephens BY, Wright AN, Fadel PJ. Impact of breakthrough COVID-19 cases during the omicron wave on vascular health and cardiac autonomic function in young adults. Am J Physiol Heart Circ Physiol. 2022;323(1):H59&#x2013;H64. doi: 10.1152/ajpheart.00189.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00189.2022</ArticleId><ArticleId IdType="pmc">PMC9169822</ArticleId><ArticleId IdType="pubmed">35594069</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>